Checkpoint Surgical
4 known investors
Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery. The company produces ACMShield, a dehydrated placental membrane allograft used as a protective barrier in surgical applications.
Founders & leadership
TA
Tracy A. MarshbanksDirector
GB
Geoffrey B. ThropeExecutive Officer, Director
LM
Leonard M. CosentinoExecutive Officer, Director
MA
Marilyn A. EiseleExecutive Officer
KM
Kevin M. ScanlanExecutive Officer
DB
Donald B. HubbardExecutive Officer
Investors · 4
Reported raises · per SEC filings
Form D private placements$4MraisedJun 2024 · 42 investors · Other
Rule 506(b)$13MraisedJun 2021 · 6 investors · Other Health Care
Rule 506(b)$1.9MraisedMay 2020 · 10 investors · Other Health Care
Rule 506(b)$8.8MraisedSep 2018 · 31 investors · Other Health Care
Rule 506(b)$7.5MraisedNov 2015 · 29 investors · Other Health Care
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.